nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—ADRA2A—type 2 diabetes mellitus	0.161	0.513	CbGaD
Pseudoephedrine—TNF—type 2 diabetes mellitus	0.153	0.487	CbGaD
Pseudoephedrine—Amphetamine—Nateglinide—type 2 diabetes mellitus	0.0949	0.337	CrCrCtD
Pseudoephedrine—Dextroamphetamine—Nateglinide—type 2 diabetes mellitus	0.0949	0.337	CrCrCtD
Pseudoephedrine—Methamphetamine—Nateglinide—type 2 diabetes mellitus	0.0922	0.327	CrCrCtD
Pseudoephedrine—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0457	0.266	CbGbCtD
Pseudoephedrine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.035	0.204	CbGbCtD
Pseudoephedrine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0335	0.195	CbGbCtD
Pseudoephedrine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0169	0.0985	CbGbCtD
Pseudoephedrine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0156	0.0909	CbGbCtD
Pseudoephedrine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0128	0.0747	CbGbCtD
Pseudoephedrine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0123	0.0716	CbGbCtD
Pseudoephedrine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00272	0.12	CbGeAlD
Pseudoephedrine—NFATC1—cardiovascular system—type 2 diabetes mellitus	0.00185	0.0817	CbGeAlD
Pseudoephedrine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00183	0.0808	CbGeAlD
Pseudoephedrine—IL2—cardiovascular system—type 2 diabetes mellitus	0.00169	0.0747	CbGeAlD
Pseudoephedrine—IL2—kidney—type 2 diabetes mellitus	0.00165	0.0731	CbGeAlD
Pseudoephedrine—NFATC1—adipose tissue—type 2 diabetes mellitus	0.00163	0.072	CbGeAlD
Pseudoephedrine—SLC6A3—nerve—type 2 diabetes mellitus	0.00127	0.0563	CbGeAlD
Pseudoephedrine—Etomidate—SLC2A1—type 2 diabetes mellitus	0.00124	0.396	CrCbGaD
Pseudoephedrine—IL2—liver—type 2 diabetes mellitus	0.00104	0.0462	CbGeAlD
Pseudoephedrine—SLC6A2—nerve—type 2 diabetes mellitus	0.00103	0.0454	CbGeAlD
Pseudoephedrine—MAOA—nerve—type 2 diabetes mellitus	0.000946	0.0419	CbGeAlD
Pseudoephedrine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000931	0.0412	CbGeAlD
Pseudoephedrine—Amphetamine—CARTPT—type 2 diabetes mellitus	0.000762	0.243	CrCbGaD
Pseudoephedrine—MAOA—islet of Langerhans—type 2 diabetes mellitus	0.000458	0.0203	CbGeAlD
Pseudoephedrine—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.000423	0.0187	CbGeAlD
Pseudoephedrine—MAOA—retina—type 2 diabetes mellitus	0.000392	0.0173	CbGeAlD
Pseudoephedrine—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000373	0.0165	CbGeAlD
Pseudoephedrine—MAOA—nephron tubule—type 2 diabetes mellitus	0.000369	0.0163	CbGeAlD
Pseudoephedrine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000352	0.0156	CbGeAlD
Pseudoephedrine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000335	0.0148	CbGeAlD
Pseudoephedrine—MAOA—cardiovascular system—type 2 diabetes mellitus	0.000332	0.0147	CbGeAlD
Pseudoephedrine—MAOA—kidney—type 2 diabetes mellitus	0.000324	0.0144	CbGeAlD
Pseudoephedrine—MAOA—pancreas—type 2 diabetes mellitus	0.000322	0.0143	CbGeAlD
Pseudoephedrine—MAOA—cortex of kidney—type 2 diabetes mellitus	0.000316	0.014	CbGeAlD
Pseudoephedrine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000295	0.0131	CbGeAlD
Pseudoephedrine—MAOA—adipose tissue—type 2 diabetes mellitus	0.000292	0.0129	CbGeAlD
Pseudoephedrine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000249	0.00268	CcSEcCtD
Pseudoephedrine—Angina pectoris—Losartan—type 2 diabetes mellitus	0.000249	0.00268	CcSEcCtD
Pseudoephedrine—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.000248	0.00266	CcSEcCtD
Pseudoephedrine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000247	0.0109	CbGeAlD
Pseudoephedrine—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000246	0.00264	CcSEcCtD
Pseudoephedrine—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000246	0.00264	CcSEcCtD
Pseudoephedrine—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000245	0.00264	CcSEcCtD
Pseudoephedrine—Nausea—Acarbose—type 2 diabetes mellitus	0.000244	0.00262	CcSEcCtD
Pseudoephedrine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000242	0.0107	CbGeAlD
Pseudoephedrine—Pain—Glipizide—type 2 diabetes mellitus	0.000242	0.0026	CcSEcCtD
Pseudoephedrine—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000242	0.0026	CcSEcCtD
Pseudoephedrine—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.00024	0.00258	CcSEcCtD
Pseudoephedrine—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000239	0.00257	CcSEcCtD
Pseudoephedrine—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000238	0.00256	CcSEcCtD
Pseudoephedrine—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000236	0.00253	CcSEcCtD
Pseudoephedrine—Tension—Gliclazide—type 2 diabetes mellitus	0.000235	0.00253	CcSEcCtD
Pseudoephedrine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000235	0.00252	CcSEcCtD
Pseudoephedrine—Bradycardia—Metformin—type 2 diabetes mellitus	0.000235	0.00252	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000233	0.00251	CcSEcCtD
Pseudoephedrine—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000233	0.0025	CcSEcCtD
Pseudoephedrine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000233	0.0025	CcSEcCtD
Pseudoephedrine—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000233	0.0025	CcSEcCtD
Pseudoephedrine—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000232	0.00249	CcSEcCtD
Pseudoephedrine—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000232	0.00249	CcSEcCtD
Pseudoephedrine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.00023	0.00247	CcSEcCtD
Pseudoephedrine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000229	0.00246	CcSEcCtD
Pseudoephedrine—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000227	0.00244	CcSEcCtD
Pseudoephedrine—Pain—Sitagliptin—type 2 diabetes mellitus	0.000225	0.00242	CcSEcCtD
Pseudoephedrine—Tremor—Gliclazide—type 2 diabetes mellitus	0.000225	0.00241	CcSEcCtD
Pseudoephedrine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000224	0.00992	CbGeAlD
Pseudoephedrine—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000223	0.0024	CcSEcCtD
Pseudoephedrine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000221	0.00238	CcSEcCtD
Pseudoephedrine—Agitation—Gliclazide—type 2 diabetes mellitus	0.00022	0.00237	CcSEcCtD
Pseudoephedrine—Confusional state—Glyburide—type 2 diabetes mellitus	0.00022	0.00236	CcSEcCtD
Pseudoephedrine—Sweating—Losartan—type 2 diabetes mellitus	0.000219	0.00235	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000218	0.00234	CcSEcCtD
Pseudoephedrine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000218	0.00234	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000217	0.00233	CcSEcCtD
Pseudoephedrine—Rash—Repaglinide—type 2 diabetes mellitus	0.000216	0.00232	CcSEcCtD
Pseudoephedrine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000216	0.00232	CcSEcCtD
Pseudoephedrine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000216	0.00232	CcSEcCtD
Pseudoephedrine—Headache—Repaglinide—type 2 diabetes mellitus	0.000214	0.0023	CcSEcCtD
Pseudoephedrine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000214	0.0023	CcSEcCtD
Pseudoephedrine—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.000214	0.00229	CcSEcCtD
Pseudoephedrine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000212	0.00228	CcSEcCtD
Pseudoephedrine—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000212	0.00228	CcSEcCtD
Pseudoephedrine—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000212	0.00228	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000211	0.00226	CcSEcCtD
Pseudoephedrine—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.00021	0.00225	CcSEcCtD
Pseudoephedrine—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000209	0.00225	CcSEcCtD
Pseudoephedrine—Anorexia—Glyburide—type 2 diabetes mellitus	0.000208	0.00223	CcSEcCtD
Pseudoephedrine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000207	0.00223	CcSEcCtD
Pseudoephedrine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000207	0.00222	CcSEcCtD
Pseudoephedrine—ADRA1A—liver—type 2 diabetes mellitus	0.000207	0.00915	CbGeAlD
Pseudoephedrine—MAOA—liver—type 2 diabetes mellitus	0.000205	0.00907	CbGeAlD
Pseudoephedrine—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000204	0.00219	CcSEcCtD
Pseudoephedrine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000204	0.00219	CcSEcCtD
Pseudoephedrine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000204	0.00219	CcSEcCtD
Pseudoephedrine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000203	0.00219	CcSEcCtD
Pseudoephedrine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000203	0.00218	CcSEcCtD
Pseudoephedrine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000203	0.00218	CcSEcCtD
Pseudoephedrine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000203	0.00218	CcSEcCtD
Pseudoephedrine—Vertigo—Valsartan—type 2 diabetes mellitus	0.000198	0.00213	CcSEcCtD
Pseudoephedrine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000197	0.00212	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00211	CcSEcCtD
Pseudoephedrine—Vertigo—Orlistat—type 2 diabetes mellitus	0.000196	0.0021	CcSEcCtD
Pseudoephedrine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000195	0.00209	CcSEcCtD
Pseudoephedrine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000195	0.00209	CcSEcCtD
Pseudoephedrine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000194	0.00209	CcSEcCtD
Pseudoephedrine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000194	0.00209	CcSEcCtD
Pseudoephedrine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000193	0.00207	CcSEcCtD
Pseudoephedrine—CYP2D6—kidney—type 2 diabetes mellitus	0.000193	0.00853	CbGeAlD
Pseudoephedrine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000192	0.00207	CcSEcCtD
Pseudoephedrine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000192	0.00206	CcSEcCtD
Pseudoephedrine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000192	0.00206	CcSEcCtD
Pseudoephedrine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000191	0.00205	CcSEcCtD
Pseudoephedrine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00019	0.00204	CcSEcCtD
Pseudoephedrine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000189	0.00204	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000189	0.00203	CcSEcCtD
Pseudoephedrine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000189	0.00203	CcSEcCtD
Pseudoephedrine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000188	0.00202	CcSEcCtD
Pseudoephedrine—Tremor—Metformin—type 2 diabetes mellitus	0.000188	0.00202	CcSEcCtD
Pseudoephedrine—Chest pain—Valsartan—type 2 diabetes mellitus	0.000188	0.00201	CcSEcCtD
Pseudoephedrine—Sweating—Ramipril—type 2 diabetes mellitus	0.000187	0.00201	CcSEcCtD
Pseudoephedrine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000187	0.00201	CcSEcCtD
Pseudoephedrine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000187	0.00201	CcSEcCtD
Pseudoephedrine—Tension—Irbesartan—type 2 diabetes mellitus	0.000186	0.002	CcSEcCtD
Pseudoephedrine—Chest pain—Orlistat—type 2 diabetes mellitus	0.000185	0.00199	CcSEcCtD
Pseudoephedrine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000185	0.00198	CcSEcCtD
Pseudoephedrine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000184	0.00198	CcSEcCtD
Pseudoephedrine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000183	0.00196	CcSEcCtD
Pseudoephedrine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000182	0.00196	CcSEcCtD
Pseudoephedrine—Vomiting—Glipizide—type 2 diabetes mellitus	0.00018	0.00193	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00018	0.00193	CcSEcCtD
Pseudoephedrine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000179	0.00193	CcSEcCtD
Pseudoephedrine—Rash—Glipizide—type 2 diabetes mellitus	0.000178	0.00192	CcSEcCtD
Pseudoephedrine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000178	0.00192	CcSEcCtD
Pseudoephedrine—Headache—Glipizide—type 2 diabetes mellitus	0.000177	0.00191	CcSEcCtD
Pseudoephedrine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000177	0.00191	CcSEcCtD
Pseudoephedrine—Palpitations—Metformin—type 2 diabetes mellitus	0.000177	0.0019	CcSEcCtD
Pseudoephedrine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000177	0.0019	CcSEcCtD
Pseudoephedrine—Tension—Losartan—type 2 diabetes mellitus	0.000175	0.00188	CcSEcCtD
Pseudoephedrine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000175	0.00188	CcSEcCtD
Pseudoephedrine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000174	0.00187	CcSEcCtD
Pseudoephedrine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000174	0.00187	CcSEcCtD
Pseudoephedrine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000174	0.00187	CcSEcCtD
Pseudoephedrine—Hypertension—Metformin—type 2 diabetes mellitus	0.000173	0.00186	CcSEcCtD
Pseudoephedrine—Nervousness—Losartan—type 2 diabetes mellitus	0.000173	0.00186	CcSEcCtD
Pseudoephedrine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000172	0.00185	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000172	0.00184	CcSEcCtD
Pseudoephedrine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000171	0.00184	CcSEcCtD
Pseudoephedrine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000171	0.00184	CcSEcCtD
Pseudoephedrine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000171	0.00184	CcSEcCtD
Pseudoephedrine—Chest pain—Metformin—type 2 diabetes mellitus	0.000171	0.00183	CcSEcCtD
Pseudoephedrine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00017	0.00183	CcSEcCtD
Pseudoephedrine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00017	0.00183	CcSEcCtD
Pseudoephedrine—Nausea—Glipizide—type 2 diabetes mellitus	0.000168	0.00181	CcSEcCtD
Pseudoephedrine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000168	0.0018	CcSEcCtD
Pseudoephedrine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000167	0.0018	CcSEcCtD
Pseudoephedrine—Pain—Gliclazide—type 2 diabetes mellitus	0.000167	0.0018	CcSEcCtD
Pseudoephedrine—Tremor—Losartan—type 2 diabetes mellitus	0.000167	0.00179	CcSEcCtD
Pseudoephedrine—Rash—Glimepiride—type 2 diabetes mellitus	0.000167	0.00179	CcSEcCtD
Pseudoephedrine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000166	0.00179	CcSEcCtD
Pseudoephedrine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000166	0.00178	CcSEcCtD
Pseudoephedrine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000166	0.00178	CcSEcCtD
Pseudoephedrine—Headache—Glimepiride—type 2 diabetes mellitus	0.000166	0.00178	CcSEcCtD
Pseudoephedrine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000165	0.00177	CcSEcCtD
Pseudoephedrine—Agitation—Losartan—type 2 diabetes mellitus	0.000164	0.00176	CcSEcCtD
Pseudoephedrine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000163	0.00176	CcSEcCtD
Pseudoephedrine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000163	0.00175	CcSEcCtD
Pseudoephedrine—Phenylpropanolamine—ADRA2A—type 2 diabetes mellitus	0.000162	0.0517	CrCbGaD
Pseudoephedrine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000161	0.00173	CcSEcCtD
Pseudoephedrine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000161	0.00173	CcSEcCtD
Pseudoephedrine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000161	0.00173	CcSEcCtD
Pseudoephedrine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000161	0.00173	CcSEcCtD
Pseudoephedrine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00016	0.00172	CcSEcCtD
Pseudoephedrine—Vertigo—Losartan—type 2 diabetes mellitus	0.00016	0.00172	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000158	0.0017	CcSEcCtD
Pseudoephedrine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000158	0.0017	CcSEcCtD
Pseudoephedrine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000158	0.00169	CcSEcCtD
Pseudoephedrine—Palpitations—Losartan—type 2 diabetes mellitus	0.000157	0.00169	CcSEcCtD
Pseudoephedrine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000157	0.00169	CcSEcCtD
Pseudoephedrine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000157	0.00168	CcSEcCtD
Pseudoephedrine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000156	0.00168	CcSEcCtD
Pseudoephedrine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000156	0.00168	CcSEcCtD
Pseudoephedrine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000156	0.00168	CcSEcCtD
Pseudoephedrine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000156	0.00168	CcSEcCtD
Pseudoephedrine—Anorexia—Metformin—type 2 diabetes mellitus	0.000156	0.00168	CcSEcCtD
Pseudoephedrine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000155	0.00166	CcSEcCtD
Pseudoephedrine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000154	0.00166	CcSEcCtD
Pseudoephedrine—Pain—Orlistat—type 2 diabetes mellitus	0.000152	0.00163	CcSEcCtD
Pseudoephedrine—Chest pain—Losartan—type 2 diabetes mellitus	0.000152	0.00163	CcSEcCtD
Pseudoephedrine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000152	0.00163	CcSEcCtD
Pseudoephedrine—Anxiety—Losartan—type 2 diabetes mellitus	0.000151	0.00162	CcSEcCtD
Pseudoephedrine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000151	0.00162	CcSEcCtD
Pseudoephedrine—Rash—Bromocriptine—type 2 diabetes mellitus	0.00015	0.00161	CcSEcCtD
Pseudoephedrine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00015	0.00161	CcSEcCtD
Pseudoephedrine—Tension—Ramipril—type 2 diabetes mellitus	0.00015	0.00161	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000149	0.0016	CcSEcCtD
Pseudoephedrine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000149	0.0016	CcSEcCtD
Pseudoephedrine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000148	0.00159	CcSEcCtD
Pseudoephedrine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000147	0.00158	CcSEcCtD
Pseudoephedrine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000147	0.00158	CcSEcCtD
Pseudoephedrine—Confusional state—Losartan—type 2 diabetes mellitus	0.000147	0.00157	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000146	0.00157	CcSEcCtD
Pseudoephedrine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000146	0.00157	CcSEcCtD
Pseudoephedrine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000144	0.00155	CcSEcCtD
Pseudoephedrine—Tremor—Ramipril—type 2 diabetes mellitus	0.000143	0.00154	CcSEcCtD
Pseudoephedrine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000142	0.00153	CcSEcCtD
Pseudoephedrine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000142	0.00152	CcSEcCtD
Pseudoephedrine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000142	0.00152	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000141	0.00151	CcSEcCtD
Pseudoephedrine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00014	0.00151	CcSEcCtD
Pseudoephedrine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00014	0.00151	CcSEcCtD
Pseudoephedrine—Agitation—Ramipril—type 2 diabetes mellitus	0.00014	0.00151	CcSEcCtD
Pseudoephedrine—Anorexia—Losartan—type 2 diabetes mellitus	0.000139	0.00149	CcSEcCtD
Pseudoephedrine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000139	0.00149	CcSEcCtD
Pseudoephedrine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000138	0.00148	CcSEcCtD
Pseudoephedrine—Rash—Glyburide—type 2 diabetes mellitus	0.000137	0.00148	CcSEcCtD
Pseudoephedrine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000137	0.00147	CcSEcCtD
Pseudoephedrine—Vertigo—Ramipril—type 2 diabetes mellitus	0.000137	0.00147	CcSEcCtD
Pseudoephedrine—Headache—Glyburide—type 2 diabetes mellitus	0.000136	0.00147	CcSEcCtD
Pseudoephedrine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000136	0.00146	CcSEcCtD
Pseudoephedrine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000135	0.00145	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000135	0.00145	CcSEcCtD
Pseudoephedrine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000134	0.00144	CcSEcCtD
Pseudoephedrine—Pain—Irbesartan—type 2 diabetes mellitus	0.000132	0.00142	CcSEcCtD
Pseudoephedrine—Insomnia—Losartan—type 2 diabetes mellitus	0.000131	0.00141	CcSEcCtD
Pseudoephedrine—Chest pain—Ramipril—type 2 diabetes mellitus	0.00013	0.0014	CcSEcCtD
Pseudoephedrine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00013	0.00139	CcSEcCtD
Pseudoephedrine—Anxiety—Ramipril—type 2 diabetes mellitus	0.00013	0.00139	CcSEcCtD
Pseudoephedrine—Nausea—Glyburide—type 2 diabetes mellitus	0.000129	0.00139	CcSEcCtD
Pseudoephedrine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000129	0.00139	CcSEcCtD
Pseudoephedrine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000129	0.00139	CcSEcCtD
Pseudoephedrine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000128	0.00137	CcSEcCtD
Pseudoephedrine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000127	0.00137	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000127	0.00137	CcSEcCtD
Pseudoephedrine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000126	0.00136	CcSEcCtD
Pseudoephedrine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000126	0.00135	CcSEcCtD
Pseudoephedrine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000124	0.00134	CcSEcCtD
Pseudoephedrine—Pain—Losartan—type 2 diabetes mellitus	0.000124	0.00134	CcSEcCtD
Pseudoephedrine—Rash—Gliclazide—type 2 diabetes mellitus	0.000123	0.00133	CcSEcCtD
Pseudoephedrine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000123	0.00132	CcSEcCtD
Pseudoephedrine—Headache—Gliclazide—type 2 diabetes mellitus	0.000123	0.00132	CcSEcCtD
Pseudoephedrine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000122	0.00131	CcSEcCtD
Pseudoephedrine—CYP2D6—liver—type 2 diabetes mellitus	0.000122	0.00539	CbGeAlD
Pseudoephedrine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000122	0.00131	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000121	0.00129	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00012	0.00129	CcSEcCtD
Pseudoephedrine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000119	0.00128	CcSEcCtD
Pseudoephedrine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000119	0.00128	CcSEcCtD
Pseudoephedrine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000117	0.00126	CcSEcCtD
Pseudoephedrine—Asthenia—Metformin—type 2 diabetes mellitus	0.000117	0.00126	CcSEcCtD
Pseudoephedrine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000116	0.00125	CcSEcCtD
Pseudoephedrine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000115	0.00123	CcSEcCtD
Pseudoephedrine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000114	0.00123	CcSEcCtD
Pseudoephedrine—Rash—Valsartan—type 2 diabetes mellitus	0.000113	0.00122	CcSEcCtD
Pseudoephedrine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000113	0.00122	CcSEcCtD
Pseudoephedrine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000113	0.00121	CcSEcCtD
Pseudoephedrine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000113	0.00121	CcSEcCtD
Pseudoephedrine—Headache—Valsartan—type 2 diabetes mellitus	0.000113	0.00121	CcSEcCtD
Pseudoephedrine—Phenylpropanolamine—CYP1A2—type 2 diabetes mellitus	0.000113	0.0359	CrCbGaD
Pseudoephedrine—Rash—Orlistat—type 2 diabetes mellitus	0.000112	0.0012	CcSEcCtD
Pseudoephedrine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000112	0.0012	CcSEcCtD
Pseudoephedrine—Headache—Orlistat—type 2 diabetes mellitus	0.000111	0.0012	CcSEcCtD
Pseudoephedrine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000111	0.00119	CcSEcCtD
Pseudoephedrine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000111	0.00119	CcSEcCtD
Pseudoephedrine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.00011	0.00118	CcSEcCtD
Pseudoephedrine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000108	0.00116	CcSEcCtD
Pseudoephedrine—Dizziness—Metformin—type 2 diabetes mellitus	0.000108	0.00116	CcSEcCtD
Pseudoephedrine—Nausea—Valsartan—type 2 diabetes mellitus	0.000107	0.00115	CcSEcCtD
Pseudoephedrine—Nausea—Orlistat—type 2 diabetes mellitus	0.000105	0.00113	CcSEcCtD
Pseudoephedrine—Asthenia—Losartan—type 2 diabetes mellitus	0.000104	0.00112	CcSEcCtD
Pseudoephedrine—Vomiting—Metformin—type 2 diabetes mellitus	0.000104	0.00112	CcSEcCtD
Pseudoephedrine—Rash—Metformin—type 2 diabetes mellitus	0.000103	0.00111	CcSEcCtD
Pseudoephedrine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000103	0.00111	CcSEcCtD
Pseudoephedrine—Methamphetamine—ADRA2A—type 2 diabetes mellitus	0.000103	0.0328	CrCbGaD
Pseudoephedrine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000103	0.0011	CcSEcCtD
Pseudoephedrine—Headache—Metformin—type 2 diabetes mellitus	0.000103	0.0011	CcSEcCtD
Pseudoephedrine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000102	0.0011	CcSEcCtD
Pseudoephedrine—Benzyl alcohol—CYP2E1—type 2 diabetes mellitus	0.000102	0.0325	CrCbGaD
Pseudoephedrine—Phentermine—CYP1A2—type 2 diabetes mellitus	0.0001	0.032	CrCbGaD
Pseudoephedrine—Body temperature increased—Ramipril—type 2 diabetes mellitus	9.85e-05	0.00106	CcSEcCtD
Pseudoephedrine—Vomiting—Irbesartan—type 2 diabetes mellitus	9.82e-05	0.00106	CcSEcCtD
Pseudoephedrine—Selegiline—CYP2E1—type 2 diabetes mellitus	9.76e-05	0.0311	CrCbGaD
Pseudoephedrine—Rash—Irbesartan—type 2 diabetes mellitus	9.74e-05	0.00105	CcSEcCtD
Pseudoephedrine—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.73e-05	0.00105	CcSEcCtD
Pseudoephedrine—Nausea—Metformin—type 2 diabetes mellitus	9.72e-05	0.00104	CcSEcCtD
Pseudoephedrine—Headache—Irbesartan—type 2 diabetes mellitus	9.68e-05	0.00104	CcSEcCtD
Pseudoephedrine—Benzyl alcohol—CYP1A2—type 2 diabetes mellitus	9.67e-05	0.0309	CrCbGaD
Pseudoephedrine—Dizziness—Losartan—type 2 diabetes mellitus	9.61e-05	0.00103	CcSEcCtD
Pseudoephedrine—Atomoxetine—HTR2C—type 2 diabetes mellitus	9.32e-05	0.0298	CrCbGaD
Pseudoephedrine—Selegiline—CYP1A2—type 2 diabetes mellitus	9.28e-05	0.0296	CrCbGaD
Pseudoephedrine—Vomiting—Losartan—type 2 diabetes mellitus	9.24e-05	0.000993	CcSEcCtD
Pseudoephedrine—Nausea—Irbesartan—type 2 diabetes mellitus	9.18e-05	0.000986	CcSEcCtD
Pseudoephedrine—Rash—Losartan—type 2 diabetes mellitus	9.17e-05	0.000985	CcSEcCtD
Pseudoephedrine—Dermatitis—Losartan—type 2 diabetes mellitus	9.16e-05	0.000984	CcSEcCtD
Pseudoephedrine—Headache—Losartan—type 2 diabetes mellitus	9.11e-05	0.000979	CcSEcCtD
Pseudoephedrine—Asthenia—Ramipril—type 2 diabetes mellitus	8.94e-05	0.000961	CcSEcCtD
Pseudoephedrine—Nausea—Losartan—type 2 diabetes mellitus	8.63e-05	0.000928	CcSEcCtD
Pseudoephedrine—Dizziness—Ramipril—type 2 diabetes mellitus	8.24e-05	0.000886	CcSEcCtD
Pseudoephedrine—Vomiting—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000852	CcSEcCtD
Pseudoephedrine—Rash—Ramipril—type 2 diabetes mellitus	7.86e-05	0.000844	CcSEcCtD
Pseudoephedrine—Dermatitis—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000844	CcSEcCtD
Pseudoephedrine—Headache—Ramipril—type 2 diabetes mellitus	7.81e-05	0.000839	CcSEcCtD
Pseudoephedrine—Nausea—Ramipril—type 2 diabetes mellitus	7.4e-05	0.000796	CcSEcCtD
Pseudoephedrine—Benzyl alcohol—CYP3A4—type 2 diabetes mellitus	6.4e-05	0.0204	CrCbGaD
Pseudoephedrine—Selegiline—CYP3A4—type 2 diabetes mellitus	6.14e-05	0.0196	CrCbGaD
Pseudoephedrine—Atomoxetine—CYP3A4—type 2 diabetes mellitus	4.66e-05	0.0149	CrCbGaD
Pseudoephedrine—ADRA2A—Metabolism—GNB3—type 2 diabetes mellitus	2.96e-06	2.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.96e-06	2.63e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	2.96e-06	2.62e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	2.96e-06	2.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—HMOX1—type 2 diabetes mellitus	2.95e-06	2.61e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PPARG—type 2 diabetes mellitus	2.95e-06	2.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.94e-06	2.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	2.93e-06	2.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.92e-06	2.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.91e-06	2.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CAT—type 2 diabetes mellitus	2.91e-06	2.58e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	2.9e-06	2.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.9e-06	2.57e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—INS—type 2 diabetes mellitus	2.89e-06	2.56e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	2.88e-06	2.55e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	2.88e-06	2.55e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	2.88e-06	2.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GCG—type 2 diabetes mellitus	2.87e-06	2.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.87e-06	2.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.87e-06	2.55e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	2.86e-06	2.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.84e-06	2.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.84e-06	2.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.83e-06	2.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOB—type 2 diabetes mellitus	2.83e-06	2.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.82e-06	2.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.82e-06	2.49e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	2.81e-06	2.49e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	2.78e-06	2.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.76e-06	2.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TGFB1—type 2 diabetes mellitus	2.76e-06	2.45e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.76e-06	2.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.75e-06	2.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GSTM1—type 2 diabetes mellitus	2.75e-06	2.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.7e-06	2.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	2.7e-06	2.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—LPL—type 2 diabetes mellitus	2.7e-06	2.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.69e-06	2.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.69e-06	2.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.67e-06	2.36e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ALB—type 2 diabetes mellitus	2.65e-06	2.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.64e-06	2.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	2.64e-06	2.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ADCY5—type 2 diabetes mellitus	2.64e-06	2.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.64e-06	2.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GPX1—type 2 diabetes mellitus	2.63e-06	2.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.63e-06	2.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AVP—type 2 diabetes mellitus	2.63e-06	2.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.62e-06	2.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.61e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	2.58e-06	2.29e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	2.58e-06	2.29e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	2.58e-06	2.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.58e-06	2.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.58e-06	2.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.57e-06	2.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	2.57e-06	2.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CD36—type 2 diabetes mellitus	2.56e-06	2.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOB—type 2 diabetes mellitus	2.54e-06	2.25e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	2.54e-06	2.25e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—NOS3—type 2 diabetes mellitus	2.54e-06	2.25e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PIK3R1—type 2 diabetes mellitus	2.54e-06	2.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.53e-06	2.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPP2CA—type 2 diabetes mellitus	2.53e-06	2.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.52e-06	2.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.52e-06	2.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	2.51e-06	2.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	2.51e-06	2.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.51e-06	2.23e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	2.51e-06	2.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.51e-06	2.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.5e-06	2.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.5e-06	2.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.49e-06	2.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.48e-06	2.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.47e-06	2.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.46e-06	2.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.46e-06	2.18e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	2.46e-06	2.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AVP—type 2 diabetes mellitus	2.44e-06	2.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.44e-06	2.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.43e-06	2.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.43e-06	2.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—MTHFR—type 2 diabetes mellitus	2.43e-06	2.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LPL—type 2 diabetes mellitus	2.43e-06	2.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.42e-06	2.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.4e-06	2.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARA—type 2 diabetes mellitus	2.38e-06	2.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.38e-06	2.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.37e-06	2.1e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	2.36e-06	2.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOB—type 2 diabetes mellitus	2.36e-06	2.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.35e-06	2.08e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	2.34e-06	2.07e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	2.34e-06	2.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.32e-06	2.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.32e-06	2.06e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—type 2 diabetes mellitus	2.32e-06	2.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AGT—type 2 diabetes mellitus	2.31e-06	2.05e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	2.28e-06	2.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.28e-06	2.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CALM1—type 2 diabetes mellitus	2.27e-06	2.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOE—type 2 diabetes mellitus	2.26e-06	2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LPL—type 2 diabetes mellitus	2.26e-06	2e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.24e-06	1.99e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	2.24e-06	1.99e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	2.24e-06	1.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.24e-06	1.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOA1—type 2 diabetes mellitus	2.24e-06	1.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.21e-06	1.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.19e-06	1.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	2.19e-06	1.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	2.15e-06	1.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.12e-06	1.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.11e-06	1.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	2.1e-06	1.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.08e-06	1.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.08e-06	1.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.08e-06	1.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.08e-06	1.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	2.08e-06	1.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.08e-06	1.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.07e-06	1.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.07e-06	1.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.04e-06	1.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.03e-06	1.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.03e-06	1.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.03e-06	1.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.03e-06	1.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—C3—type 2 diabetes mellitus	2.03e-06	1.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.02e-06	1.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.01e-06	1.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.97e-06	1.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	1.97e-06	1.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.94e-06	1.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.93e-06	1.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	1.93e-06	1.71e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.93e-06	1.71e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.93e-06	1.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.93e-06	1.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	1.93e-06	1.71e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.92e-06	1.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	1.92e-06	1.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.92e-06	1.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.9e-06	1.68e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.9e-06	1.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.89e-06	1.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.89e-06	1.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.88e-06	1.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.88e-06	1.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.87e-06	1.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.84e-06	1.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.84e-06	1.63e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.84e-06	1.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.82e-06	1.61e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.79e-06	1.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.78e-06	1.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.77e-06	1.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	1.77e-06	1.57e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.76e-06	1.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.74e-06	1.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.73e-06	1.54e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.72e-06	1.52e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.71e-06	1.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.71e-06	1.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.69e-06	1.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	1.69e-06	1.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.69e-06	1.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.68e-06	1.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.68e-06	1.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.67e-06	1.48e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.67e-06	1.48e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.65e-06	1.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.62e-06	1.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.61e-06	1.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.6e-06	1.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.6e-06	1.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.59e-06	1.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.59e-06	1.41e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.58e-06	1.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.58e-06	1.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.56e-06	1.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.56e-06	1.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.56e-06	1.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.55e-06	1.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.55e-06	1.38e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.55e-06	1.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.55e-06	1.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.52e-06	1.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.52e-06	1.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.51e-06	1.34e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.5e-06	1.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.5e-06	1.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.48e-06	1.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.48e-06	1.31e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.48e-06	1.31e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.47e-06	1.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.47e-06	1.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.46e-06	1.3e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.46e-06	1.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.43e-06	1.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.43e-06	1.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.42e-06	1.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.42e-06	1.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.39e-06	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.36e-06	1.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.36e-06	1.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.33e-06	1.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.33e-06	1.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.31e-06	1.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.29e-06	1.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.29e-06	1.14e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.28e-06	1.14e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.26e-06	1.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.25e-06	1.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.22e-06	1.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.22e-06	1.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.22e-06	1.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.21e-06	1.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.21e-06	1.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.2e-06	1.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.19e-06	1.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.19e-06	1.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.19e-06	1.05e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—type 2 diabetes mellitus	1.17e-06	1.03e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.15e-06	1.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.14e-06	1.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.13e-06	9.99e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.12e-06	9.96e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.1e-06	9.78e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.1e-06	9.78e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.1e-06	9.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.1e-06	9.73e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.05e-06	9.29e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.02e-06	9.04e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.01e-06	8.95e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.01e-06	8.93e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.88e-07	8.76e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	9.39e-07	8.32e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.37e-07	8.3e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	9.18e-07	8.14e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.18e-07	8.14e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.66e-07	7.68e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.47e-07	7.51e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	7.79e-07	6.9e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.6e-07	6.73e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.06e-07	6.25e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.01e-07	6.21e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.51e-07	5.77e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	5.07e-07	4.5e-06	CbGpPWpGaD
